Similarly, in hepatocellular carcinoma samples, methylation of the promoter of BCL2L10 (Bcl-2-like protein 10) was associated with a decreased expression of BCL2L10 [21]. The gene discussed is BCL2L10; the disease is hepatocellular carcinoma.